Smell Loss

Losing Sense of Smell

Most people do not connect losing their sense of smell to a Parkinson's diagnosis. After developing motor symptoms and talking to a doctor, however, they may recall that years or even decades earlier they had lost the ability to smell. This condition is called hyposmia and can impact quality of life — affecting taste and, in some cases, leading to weight loss.

While scientists do not know why smell loss occurs in Parkinson's, one popular theory is that the Parkinson's process may start in the olfactory bulb, the part of the brain that controls sense of smell, and the gut. Some researchers believe clumps of the protein alpha-synuclein (a hallmark of Parkinson's disease) may form in these parts of the body first, before migrating to other parts of the brain.

Early Diagnosis of Parkinson's Disease

While there is no treatment for smell loss, this symptom is valuable in research toward earlier diagnosis and therapeutic intervention.

Early detection is a crucial step to understanding the causes of and developing better treatments for Parkinson's disease (PD). Even before the typical tremor and slowness of movement occur, it may be possible to detect early changes in the brain and symptoms that are associated with PD.

The Michael J. Fox Foundation's landmark study, the Parkinson's Progression Markers Initiative (PPMI), is studying people with smell loss. Some people who enrolled in PPMI with only smell loss have since developed Parkinson's disease. By looking back at the brain scans and blood tests those volunteers contributed before their Parkinson's diagnosis, scientists can understand what is happening in the earliest stages of the disease. That information could lead to early diagnostic tests and treatments to slow or stop Parkinson's progression, perhaps before tremor or slowness begin.

The medical information contained in this article is for general information purposes only. The Michael J. Fox Foundation for Parkinson's Research has a policy of refraining from advocating, endorsing or promoting any drug therapy, course of treatment, or specific company or institution. It is crucial that care and treatment decisions related to Parkinson's disease and any other medical condition be made in consultation with a physician or other qualified medical professional.